{"id":54406,"name":"SOLENO THERAPEUTICS, INC.","slug":"soleno-therapeutics-inc","state":"CA","country":"United States of America","description":"Soleno is focused on development of novel therapeutics for treatment of rare diseases.","totalSpending":550000,"filings":13,"yearlySpending":[{"year":2023,"income":140000},{"year":2024,"income":210000},{"year":2025,"income":200000}],"issues":[{"code":"PHA","display":"Pharmacy"},{"code":"HCR","display":"Health Issues"}],"firms":["THE KPM GROUP DC LLC"],"lobbyists":["KATHERINE LANDES","ALEXANDER ROOT","BRANDEN CORDEIRO","JACOB JACKSON","PAULA GUTIERREZ"],"govEntities":["HOUSE OF REPRESENTATIVES","SENATE","White House Office"],"sampleDescriptions":["Rare disease drug development Orphan Drug Act Orphan Drug Tax Credit Priority Review Voucher Expedited approval pathways Patient-focused Drug Development","Rare disease drug development Orphan Drug Act Orphan Drug Tax Credit Priority Review Voucher Expedited approval pathways Patient-focused Drug Development","H.R.2471 - Consolidated Appropriations Act, 2022 (117th)","Senate HELP Minority- FDA Modernization H.R. 2471 - Consolidated Appropriations Act, 2022 (117th) H.R. 1350 - Camerons Law S. 1906 - Promising Pathway Act","H.R.4408/S.1906 - Promising Pathway Act H.R. 6888/S. 4071 - Helping Experts Accelerate Rare Treatments (HEART) Act [117th Congress] H.R. 2471 - Consolidated Appropriations Act, 2022 [117th Congress]"]}